The Comparison of Hearing Impairment between the Subjects with Type-2 Diabetes and the Subjects without Diabetes, working in Phramongkutklao hospital.
Keywords:
Prevalence, Screening, Hearing impairment, Type-2 DiabetesAbstract
Objective: To determine the prevalence of hearing impairment using screening tests by Weber/Rinne test, Five Minute Hearing test (FMHT) and Calibrated Finger-Rubbing Auditory Screening Test (CALFRAST) comparing between the subjects with type-2 diabetes and the subjects without diabetes and to examine the risk factors of hearing impairment among subjects with type-2 diabetes.
Design: Cross-sectional study.
Materials and Methods: Data comes from 372 participants, aged 18-60 years, with diagnosed or undiagnosed diabetes who are working in Phramongkutklao hospital and have had general examination from December, 2019 to January, 2020. We define hearing impairment as the Weber/Rinne tunning fork test is positive and compared with the other tests and identified risk factors of hearing impairment among subjects with type-2 diabetes.
Results: The result shows that the prevalence of hearing impairment in diabetes group compared with non-diabetes group by using Weber/Rinne test is 18.7% and 6% (p-value<0.001). The risk factors of hearing impairment among subject with type-2 diabetes are age (Adjusted OR=1.310, P=0.004, 95%CI=1.088-1.577), male sex (Adjusted OR=7.033, P=0.045, 95%CI=1.043-47.432) and time diagnosis diabetes above 6 years (Adjusted OR=9.119, P=0.032, 95%CI=1.202-69.162).
Conclusions: Hearing impairment should be considered as one of the complications of diabetes mellitus. Diabetes patients should be evaluate for hearing impairment at first time when diagnosis diabetes mellitus and follow-up is necessary in order to early detection and prompt management.
References
2. Yueh B, Shapiro N, MacLean CH, Shekelle PG. Screening and management of adult hearing loss in primary care: scientific review. JAMA 2003;289:1976-85.
3. Cruickshanks KJ, Tweed TS, Wiley TL, Klein BE, Klein R, Chappell R, et al. The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study. Arch Otolaryngol Head Neck Surg 2003;129:1041-46.
4. American Diabetes Association. Diabetes and Hearing Loss. [online]. 2017 [cited 2013 Sep.30]. Available from: http://www.diabetes.org/living-with-diabetes/treatment-and-care/seniors/diabetes-and-hearing-loss.html
5. Horikawa C, Kodama S, Tanaka S, Fujihara K, Hirasawa R, Yachi Y, et al. Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol Metab 2013, 98:51-8.
6. กองโรคจากการประกอบอาชีพและสิ่งแวดล้อม กรมควบคุมโรค. ข้อมูลผู้ป่วยโรคการได้ยินเสื่อมเหตุเสียงดัง. นนทบุรี: กระทรวงสาธารณสุข; 2559.
7. สุกัญญา มหาโชคลาภ. การสูญเสียการได้ยินในผู้ป่วยโรคเบาหวาน โรงพยาบาลระนอง. วารสารวิชาการแพทย์เขต 11 2561;32:1127-34.
8. Pirozzo S, Papinczak T, Glasziou P. Whispered voice test for screening for hearing impairment in adult and children: systematic review. BMJ 2003; 327:967-72.
9. Torres-Russotto D, Landau WM, Harding GW, Bohne BA, Sun K, Sinattra PM. Calibrated finger rub auditory screening test (CALFRAST). Neurology 2009;72:1595-600.
10. Vikram KB, Naseeruddin K. Combined tuning fork tests in hearing loss: explorative clinical study of the patterns. J Otolaryngol 2004; 33:227-34.
11. Kasemsiri P, Yimtae K, Thanaviratananitch P, Siripaopradith P. Development and Validation of a Short Version of the Thai Five-Minute Hearing Test to Screen Hearing in the Community. J Med Assoc Thai 2017;100:Suppl 6 S165-S73.
12. Lerman-Garber I, Cuevas-Ramos D, Valdes S, Enriquez L, Lobato M, Osornio M, et al. Sensorineural hearing loss-a common finding in early-onset type 2 diabetes mellitus. Endocrine Practice 2012;18:549-57.
Downloads
Published
How to Cite
Issue
Section
License
บทความที่ลงพิมพ์ในวารสารเวชศาสตร์ป้องกันแห่งประเทศไทย ถือเป็นผลงานวิชาการ งานวิจัย วิเคราะห์ วิจารณ์ ตลอดจนเป็นความเห็นส่วนตัวของผู้นิพนธ์ กองบรรณาธิการไม่จำเป็นต้องเห็นด้วยเสมอไปและผู้นิพนธ์จะต้องรับผิดชอบต่อบทความของตนเอง
